Literature DB >> 25957879

Angiotensin-converting enzyme (ACE) gene insertion/deletion polymorphism is not a risk factor for hypertension in SLE nephritis.

Vir S Negi1, Panneer Devaraju, Reena Gulati.   

Abstract

SLE is a systemic autoimmune disease with high prevalence of hypertension. Around 40-75 % of SLE patients develop nephritis, a major cause of hypertension and mortality. Angiotensin-converting enzyme (ACE) maintains the blood pressure and blood volume homeostasis. An insertion/deletion (I/D) polymorphism in intron 16 of ACE gene was reported to influence the development of hypertension, nephritis, and cardiovascular diseases in different ethnic populations. Despite compelling evidence for the high prevalence of hypertension in individuals with SLE, underlying factors for its development are not well studied. With this background, we analyzed the influence of ACE insertion/deletion polymorphism on susceptibility to SLE, development of nephritis and hypertension, other clinical features and autoantibody phenotype in South Indian SLE patients. Three hundred patients with SLE and 460 age and sex similar ethnicity matched individuals were included as patients and healthy controls, respectively. The ACE gene insertion/deletion polymorphism was analyzed by PCR. Insertion (I) and deletion (D) alleles were observed to be equally distributed among patients (57 and 43 %) and controls (59 and 41 %), respectively. The mutant (D) allele did not confer significant risk for SLE (II vs. ID: p = 0.4, OR 1.15, 95 % CI 0.8-1.6; II vs. DD: p = 0.34, OR 1.22, 95 % CI 0.8-1.85). There was no association of the ACE genotype or the allele with development of lupus nephritis (II vs. ID: p = 0.19, OR 1.41, 95 % CI 0.84-2.36; II vs. DD: p = 0.41, OR 0.74, 95 % CI 0.38-1.41) or hypertension (II vs. ID: p = 0.85, OR 0.9, 95 % CI 0.43-1.8; II vs. DD: p = 0.66, OR 1.217, 95 % CI 0.5-2.8). The presence of mutant allele (D) was not found to influence any clinical features or autoantibody phenotype. The insertion/deletion polymorphism of the ACE gene is not a genetic risk factor for SLE and does not influence development of hypertension or lupus nephritis in South Indian Tamils.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25957879     DOI: 10.1007/s10067-015-2954-6

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  23 in total

1.  The prevalence and incidence of biopsy-proven lupus nephritis in the UK: Evidence of an ethnic gradient.

Authors:  Mumtaz Patel; Alexandra M Clarke; Ian N Bruce; Deborah P M Symmons
Journal:  Arthritis Rheum       Date:  2006-09

2.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

3.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

4.  Association of an insertion polymorphism of angiotensin-converting enzyme gene with the activity of lupus nephritis.

Authors:  Y Akai; H Sato; M Iwano; N Kurumatani; H Kurioka; A Kubo; T Yamaguchi; H Shiiki; T Fujimoto; K Dohi
Journal:  Clin Nephrol       Date:  1999-03       Impact factor: 0.975

Review 5.  The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease.

Authors:  Giuseppe Remuzzi; Norberto Perico; Manuel Macia; Piero Ruggenenti
Journal:  Kidney Int Suppl       Date:  2005-12       Impact factor: 10.545

6.  Polymorphisms of the renin-angiotensin system genes in Brazilian patients with lupus nephropathy.

Authors:  S R S Sprovieri; Y A S Sens
Journal:  Lupus       Date:  2005       Impact factor: 2.911

7.  Angiotensin-converting enzyme gene polymorphism in patients with systemic lupus.

Authors:  I Prkacin; B Novak; J Sertić; A Mrzljak
Journal:  Acta Med Croatica       Date:  2001

8.  Familial resemblance of plasma angiotensin-converting enzyme level: the Nancy Study.

Authors:  F Cambien; F Alhenc-Gelas; B Herbeth; J L Andre; R Rakotovao; M F Gonzales; J Allegrini; C Bloch
Journal:  Am J Hum Genet       Date:  1988-11       Impact factor: 11.025

9.  Renal outcome and vascular morbidity in systemic lupus erythematosus (SLE): lack of association with the angiotensin-converting enzyme gene polymorphism.

Authors:  Y Molad; E Gal; N Magal; J Sulkes; M Mukamel; A Weinberger; S Lalazari; M Shohat
Journal:  Semin Arthritis Rheum       Date:  2000-10       Impact factor: 5.532

Review 10.  The pathophysiology of hypertension in systemic lupus erythematosus.

Authors:  Michael J Ryan
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-01-21       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.